Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma

Clinical trial NCT02481934 · COMPLETED

Trial details

NCT number: NCT02481934
Sponsor: Joaquín Martínez López, MD, PhD
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-03-01
Primary completion: 2016-07-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.